Newsletter | January 20, 2025

01.20.25 -- 5 Reasons For Pharma Revisits Of Delivery Device Strategies In 2025

SPONSOR

Join us for an engaging Drug Delivery Leader Live. Explore FDA guidance on Essential Drug Delivery Outputs (EDDOs) with practical tips and expert insights. This interactive session covers implementation strategies and key recommendations for optimizing delivery outputs in product design, development, and regulatory planning for combination products and delivery systems. Don’t miss this opportunity to enhance your understanding and refine your approach. Register today!

FEATURED EDITORIAL

5 Reasons For Pharma Revisits Of Delivery Device Strategies In 2025

As we look forward to 2025, the future of drug development appears as exciting and fast-moving as it’s ever been and is expected to be the year for pharmaceutical companies to revisit their drug delivery device strategies or risk being left behind. Here are the five reasons why.

Drug Delivery Outlook: 7 Waves To Ride In 2025 And Beyond

With a view of the evolving landscape of health policy and patient needs, I've identified seven biopharmaceutical industry trends that should drive innovation and practical implementation in drug delivery. Harmonization, digitization, quality, intelligence, and agility are among the focus areas I recommend for forward-thinking biopharmaceutical companies.

INDUSTRY INSIGHTS

Taste Masking 101: Applications And Technologies

Learn about key product parameters affecting patient acceptability, therapy adherence, and taste masking strategies, including organoleptic and barrier coating approaches and microencapsulation tech.

Nasal Vaccine Development, Manufacturing, And Device Selection

When developing a nasal delivery program, an experienced development and manufacturing partner who can see a program through small-scale clinical to commercial supply is crucial.

Patient- And Planet-Centric Bioavailability And Sustained Delivery

By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

Applying Automation To The Manufacture Of Drug Delivery Devices

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Transitioning From A Vial To PFS Or Cartridge In An Auto-Injector Device

Learn how to approach the transition of migrating from a vial to a syringe or cartridge, the necessary compatibility testing, and the stresses on the bulk product during formulation and filling.

Evolution Of Novel Polymers To Overcome Limits In Sustained Drug Delivery

Degradable polymers evolved from aliphatic polyesters to nitrogen-bearing biomaterials such as polyurethanes and polyester amides. Explore a brief history of the development of PEA polymers.

SOLUTIONS

Improve The Bioavailability Of Poorly Soluble Drugs

Valor Glass: The Future Of Glass Packaging Is Here

Highly Flexible And Customizable On-Body Delivery System Platform

Accelerate Development And Delivery Of Your Modern Medicines